#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16592	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2253	732.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	965	C	898	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16592	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2253	732.1	0	HET	.	.	.	C451T	.	451	451	C	704	704	C	993	C,T	676,258	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29898	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	821.2	0	.	n	.	0	T695C	SNP	695	695	T	1122	1122	C	932	C	869	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29898	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	821.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2065	2065	G	917	G,A,T	424,462,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29898	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	821.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2398	2398	C	905	C,G	841,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29898	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	821.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2472	2472	A	929	A,C	880,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29898	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	821.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3024	3024	C	918	C	869	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1814	folP	855	855	100.0	folP.l15.c30.ctg.1	1636	110.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1014	1016	AGC	179;181;180	A;G;C	169;167;166	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5126	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	150.4	1	SNP	p	S91F	1	.	.	271	273	TTC	604	606	TTC	181;182;181	T;T;C	172;174;172	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5126	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	150.4	1	SNP	p	G95N	0	.	.	283	285	GGC	616	618	GGC	177;176;175	G;G;C	165;162;162	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5126	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	150.4	1	SNP	p	D95G	1	.	.	283	285	GGC	616	618	GGC	177;176;175	G;G;C	165;162;162	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1470	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1299	112.5	1	SNP	p	G45D	0	.	.	133	135	GGC	431	433	GGC	182;183;180	G;G;C	166;168;166	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	834	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1122	74.0	0	.	n	.	0	A197.	DEL	197	197	A	673	673	A	199	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6180	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2902	212.0	1	SNP	p	D86N	0	.	.	256	258	GAC	533	535	GAC	242;241;241	G,C;A;C	228,1;223;231	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6180	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2902	212.0	1	SNP	p	R87I	0	.	.	259	261	CGT	536	538	CGT	242;246;247	C;G;T	230;228;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6180	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2902	212.0	1	SNP	p	S87R	1	.	.	259	261	CGT	536	538	CGT	242;246;247	C;G;T	230;228;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6180	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2902	212.0	1	SNP	p	R87W	0	.	.	259	261	CGT	536	538	CGT	242;246;247	C;G;T	230;228;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6180	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2902	212.0	1	SNP	p	S88P	0	.	.	262	264	TCC	539	541	TCC	245;246;247	T;C;C	228;230;234	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4090	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2741	148.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1564	1566	GGC	206;205;203	G;G;C,A	187;186;183,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1270	1272	GCC	210;208;206	G,A;C;C	198,1;198;196	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1273	1275	ATG	206;208;205	A;T;G	192;197;193	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1285	1287	ACC	202;203;205	A;C;C	189;190;193	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1285	1287	ACC	202;203;205	A;C;C	189;190;193	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1786	1788	ACC	238;240;240	A;C;C	218;219;223	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1840	1842	GCG	209;208;208	G,C;C,A;G	197,1;199,1;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1840	1842	GCG	209;208;208	G,C;C,A;G	197,1;199,1;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1963	1965	GGT	184;184;185	G;G;T	166;165;163	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1972	1974	AGC	178;179;179	A;G;C	161;161;157	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4110	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	171.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1990	1992	CCG	154;155;155	C,G;C,G;G	124,5;129,1;127	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6262	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3052	204.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1599	1601	CCG	254;258;252	C;C,T;G	217;226,1;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2586	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1600	160.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	471	471	C	179	C	166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1600	216.9	1	SNP	p	G120K	1	.	.	358	360	AAG	718	720	AAG	283;284;285	A;A;G	269;270;269	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1600	216.9	1	SNP	p	A121N	1	.	.	361	363	AAC	721	723	AAC	285;281;280	A;A;C,A	271;266;262,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1600	216.9	1	SNP	p	N121D	0	.	.	361	363	AAC	721	723	AAC	285;281;280	A;A;C,A	271;266;262,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12774	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4849	262.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1402	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1076	129.4	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	262;262;262	A;T;G	246;247;244	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
